Back

Effects of sodium-glucose cotransporter 2 inhibitors on pulmonary hemodynamics in chronic heart failure patients with a pulmonary artery pressure sensor.

2 September 2024 (08:00 - 08:50)
Organised by: Logo
Congress Presentation Part of: Pulmonary circulation and the right ventricle in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Evelyn Santiago-Vacas

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

8 More presentations in this session

Presentation thumbnail
Prognostic role of right ventricular-pulmonary artery coupling assessed by TAPSE/PASP ratio in patients with heart failure and mildly reduced ejection fraction
Doctor M. Ono (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Pathobiological characterization of pulmonary hypertension associated with heart failure with preserved ejection fraction
Miss L. Zimmermann (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Echocardiographic profiles of patients with CPCPH and IPCPH in HFpEF: insights from the PHHF study
Doctor E. Berthelot (Le Kremlin-Bicetre, FR)
Abstract Slides Video
Presentation thumbnail
Unravel novel therapeutic targets in heart failure and associated pulmonary hypertension
Doctor M. Alberti (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
mortality trends and effects of acute pulmonary embolism on acute right heart failure patients: a nationwide perspective
Doctor K. Ramireddy (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary circulation and the right ventricle in heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of sodium-glucose cotransporter 2 inhibitors on pulmonary hemodynamics in chronic heart failure patients and a pulmonary artery pressure sensor: does left ventricular ejection fraction matter?
thumbnail
Congress Presentation
SGLT2i downregulate the activin/inhibin and miR-1306-5p signaling pathways in patients with HFrEF and associated pulmonary hypertension: a prospective intervention study
thumbnail
Congress Presentation
Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources